<DOC>
	<DOCNO>NCT00377585</DOCNO>
	<brief_summary>The study design demonstrate meaningful difference immunogenicity candidate adjuvanted vaccine compare licensed Fluarix vaccine subject age 50 year . A control group young adult age 18 40 year include .</brief_summary>
	<brief_title>Demonstrate Superiority Immune Response Adjuvanted Influenza Vaccine Induced Adult Population</brief_title>
	<detailed_description>This study demonstrate superiority immune response adjuvanted influenza vaccine induce adult population .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The subject must healthy adult 1840 year &gt; /= 50 year . Subjects exclude take/have take chronically high dos immunosuppressant immune modify drug within six month vaccination , immunoglobulins blood product within three month vaccination , investigational product within 30 day vaccination , license vaccine within 2 ( inactivate ) 4 ( live ) week vaccination , woman pregnant lactating , subject acute clinically significant disease immunosuppressive/deficient condition , contraindication influenza vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Elderly</keyword>
	<keyword>Improved vaccine</keyword>
	<keyword>Influenza</keyword>
	<keyword>Influenza disease</keyword>
</DOC>